PATHOLOGY OF HEPATITIS- A, B, C, D, E

3,792 views 54 slides Dec 15, 2021
Slide 1
Slide 1 of 54
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54

About This Presentation

1. INTRODUCTION
2. WHAT IS HEPATITIS
3. HEPATITIS VIRUS
4. SIGNS AND SYMPTOMS'
5. ETIOLOGY
6. PATHOLOGICAL CYCLES
7. DIAGNOSIS
8. THANK YOU


Slide Content

Hepatitis

Hepatitis

» Viral hepatitis is a systemic disease with primary
inflammation of the liver by any one of a heterogeneous
group of hepatotropic viruses.

» The most common causes of viral hepatitis are the five
unrelated hepatotropic viruses Hepatitis A, Hepatitis
B, Hepatitis C, Hepatitis D, and Hepatitis E.

» In addition to the nominal hepatitis viruses, other viruses

that can also cause liver inflammation include Herpes
simplex, Cytomegalovirus, Epstein-Barr virus, or Yellow

fever. A

Clinical Terms

Hepatitis: inflammation of liver;
Acute Viral Hepatitis: symptoms last less than 6 months

Acute Hepatic Failure:is the appearance of severe complications rapidly
after the first signs of liver disease (such as jaundice), and indicates
that the liver has sustained severe damage (loss of function of 80-90% of
liver cells).Massive hepatic necrosis with impaired consciousness within
8 weeks of onset of illness.

Chronic Hepatitis: Inflammation of liver for at least 6 months

Cirrhosis: Replacement of liver tissue fibrosis(scar tissue). These
changes lead to loss of liver function.

Fulminant Hepatitis: severe impairment of hepatic functions or severe
necrosis of hepatocytes in the absence of preexisting liver disease.

Viral Hepatitis

“Infectious” — Enterically

] Y transmitted

Viral hepatitis NANB

“ \ = N y Parenterally
Serum! 一 00\ © transmitted
G

Types of Hepatitis
| 00000 sw: re nt

Hepatitis A virus Hepatitis B virus Hepatitis C virus Hepatitis D virus Hepatitis E virus
(HAV); ssRNA: (HBV): dsDNA; — (HCV); ssRNA; (HDV): ssRNA: (HEV); ssRNA;

No envelope envelope envelope envelope from no envelope
HBV
Route of Fecal-oral Parenteral, Parenteral Parenteral Fecal-oral
Transmission Vertical, Sexual.
Age affected Children Any age Adults Any age Young adults
Carrier state Nil Common Present Nil (only with Nil
HBV)
Incubation period 10-50 days (avg. 50-180 days 40-120 days 2-12 weeks 2-9 weeks.
25-30) (avg. 60-90)
Chronic infection No Yes Yes Yes No

Specific lg and Vaccine Igand Vaccine Nil HBY vaccine Nil
| Prophylaxis

HEPATITIS A

Hepatitis A

v Hepatitis A (formerly known as “infectious” hepatitis
or epidemic jaundice) is an acute infectious disease
caused by Hepatitis A virus (HAV).

v The disease is heralded by non-specific symptoms
such as fever, chills, headache, fatigue, generalized
weakness and aches and pains, followed by
anorexia, nausea, vomiting, dark urine and jaundice.

v The disease is benign with complete recovery in
several weeks.

Pathogenesis of HAV

Cause subacute disease in children & young adults.

HAV invade into human body by fecal-oral route,
multiplies in the intestinal epithelium & reaches
the liver by hematogenous spread.

After one week, the HAV reach liver cells replicate
within.Then enter intestine with bile and appear in
feces.

Incubation Period : 2 to 6 weeks.

Pathogenesis of HAV

一 After HAV replicating and discharging, liver
cells damage begin

— Animal experiment proved that immune
complex may attend the pathogenesis of HAV

— Complement level reduce the pathogenesis
maybe following:

— activated T cell secrete y-INF that promote the
representation of HLA on the liver cells,CTL
may kill the target cell infected with HAV

HEPATITIS B

Epidemiological Determinants

> Agent factor

a) AGENT: Hepatitis B Virus (HBV)

-It is a complex, 42 nm double-shelled DNA virus originally known
as “Dane Particle”.
-lt replicates in liver cell.

HBV occurs in 3 morphology form in serum:
i. Small spherical particles with an average Diameter of 22nm.
ii. Filamentous or Tubules of varying length & of 22 nm diameter.
iii. Dane particle.

Out of 3 morphology forms, only the Dane particle is considered infectious, other
circulating morphology forms are not infectious. 4

HBV Structure

Ceeyr ©The ica Companies, Ie Parmision required for reprducton or diay
Genomic DNA
(double-stranded
with partial

single strand)
Hepatitis [Envelope
B surface
antigen
(HBsAg) に
ト Nucloocapsid
(viral capsic)
Envolope lipid
[from host cell)

Hepatitis 8 e antigen ㆍ Hapaliis B core antigen
(HBeAg) (HBcA0)

Elongated

이 Complete intectious viion (b) Viral envelope particles containing HBsAg |

Serological Events

1) HBsAg :- It is the first marker to appear in blood after infection.

2) Anti-HBs(HBsAb) :-Disappearance of HBsAg and the appearance of anti-HBs
signals recovery from HBV infection, non-infectivity.

3) Anti-HBc :- IgM anti-HBc appears shortly after HBsAg is detect (HBcAg alone
dose not appear in serum)
IgM-HBc may also or can persist for 3-6 months or longer.
lgG-HBc also appear during acute hepatitis B but persist indefinitely.

4) HBeAg :-

一 HBeAg appear in blood concurrently with HBsAg, or soon afterwards.

> HBeAg is a soluble protein found only in HBeAg positive serum.

> HBeAg indicate viral replication and infectivity.

> Persistence of HBeAg in serum beyond 3 month indicate an increased like
hood of chronic hepatitis B.

Common serological Pattern in HBV
infection

HEPATITIS C

Hepatitis C

v Hepatitis C is an infectious disease affecting primarily
the liver, caused by the hepatitis C virus (HCV).

Y The infection is often asymptomatic, but chronic infection
can lead to scarring of the liver and ultimately to cirrhosis,
which is generally apparent after many years.

v It is estimated that 150-200 million people, or -3% of the
world's population, are living with chronic hepatitis C.

Y HCV infection is prevalent in India too, with an estimated
12.5 million cases.

y Overt jaundice is seen in about 5 % of patients only.

y The important part in type C hepatitis is the chronic illness.

v About 50 to 80 % of patients progress to chronic hepatitis. 4

Hepatitis C Virus

envelope glycoproteins

w HCV is a 50-60 nm virus with a linear,
single stranded RNA genome,
enclosed with in a core and
surrounded by an envelope, carrying
glycoprotein spikes.

Y” It is a member of
the Hepacivirus genus in the
family Flaviviridae.

Y” The half life of the virus particles in
the serum is around 3 hours and may
be as short as 45 minutes.

v In addition to replicating in the liver
the virus can multiply in lymphocytes.

core

envelope

approx60 nm

Structure of Hepatitis C Virus

viral RNA

HEPATITIS D

Hepatitis D

v Hepatitis D, also referred to as hepatitis D virus (HDV)
and classified as Hepatitis delta virus, is
a disease caused by a small circular enveloped RNA virus.

v HDV is considered to be a subviral satellite because it can
propagate only in the presence of the hepatitis B
virus (HBV).

Hepatitis D Virus

VIRION: spherical, 36-38
nm particle with an outer
coat composed of the
HBsAg surrounding ssRNA
genome.

Satellite virus : replicates
only in the presence of
HBV

pe 35-40 nm >

HEPATITIS E

Hepatitis E

Y Hepatitis E is a viral hepatitis (liver inflammation) caused by infection with
a virus called hepatitis E virus (HEV).

v Although Hepatitis E often causes an acute and self-limiting infection (in
that it usually goes away by itself and the patient recovers) with low
mortality rates.

v It bears a high risk of developing chronic hepatitis in immunocompromised
patients with substantial mortality rates.

v Hepatitis E occasionally develops into an acute, severe liver disease, and is
fatal in about 2% of all cases.

v In pregnant women the disease is more often severe and is associated with
a clinical syndrome called fulminant hepatic failure.

HEPATITIS G